Safety of Continuous Nebulized Albuterol for Bronchospasm in Infants and Children

Abstract

Continuous albuterol therapy appears to be safe in our patient population as there was no significant evidence of cardiotoxicity. The significance of the transient elevation of CK-MB without other evidence of cardiotoxicity remains to be determined.